Location History:
- Belleville, NJ (US) (1976 - 1978)
- Pine Brook, NJ (US) (1985 - 2003)
- Las Vagas, NV (US) (2009)
- Henderson, NV (US) (2011)
Company Filing History:
Years Active: 1976-2011
Title: Ho-Jane Shue: Innovator in Pharmaceutical Patents
Introduction
Ho-Jane Shue is a prolific inventor based in Pine Brook, NJ, who has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, his work focuses primarily on compounds that exhibit medicinal properties. His innovative spirit and dedication to research have positioned him as a notable figure in the industry.
Latest Patents
Among Ho-Jane Shue's latest patents are salts of a compound known as 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide. This patent outlines the methods of preparing maleate, tosylate, fumarate, and oxalate salts of this compound. Additionally, he has patented substituted 2-quinolyl-oxazoles that are useful as PDE4 inhibitors, expanding the therapeutic applications of his inventions.
Career Highlights
Ho-Jane Shue has had an impactful career, with significant tenures at Schering Corporation and Schering-Plough Corporation. His experience in these prominent organizations has allowed him to refine his skills in the research and development of pharmaceutical products. The combination of his expertise and passion for innovation has resulted in numerous patented inventions that contribute to advancing medical science.
Collaborations
Throughout his career, Ho-Jane Shue has collaborated with esteemed professionals, including David J. Blythin and Xiao Chen. The shared knowledge and diverse experiences amongst these collaborators have further enriched his research endeavors and led to successful patent filings, enhancing the overall impact of their work.
Conclusion
Ho-Jane Shue is an exemplary inventor whose contributions to pharmaceutical patents have the potential to transform treatment options for various medical conditions. With 27 patents to his name and ongoing innovations, he continues to play a pivotal role in the landscape of medicinal chemistry and drug development.